We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 793

Washington healthcare update - August 24, 2015
  • McGuireWoods LLP
  • USA
  • August 24 2015

This Week: FDA Begins Device User Fee Talks with Patients and Consumers Sept. 15... CMS Extends Partial Enforcement Delay of Two-Midnight Policy


CMS releases data regarding hospital and physician utilization
  • McGuireWoods LLP
  • USA
  • August 24 2015

CMS recently announced that it would be releasing Medicare hospital utilization and payment data, as well as physician and supplier utilization and


FDA flexes muscles over dietary supplements
  • McGuireWoods LLP
  • USA
  • May 5 2015

In a move designed to halt sales of popular workout stimulants, the U.S. Food and Drug Administration (FDA) recently issued warning letters to some 14


The scoop on MOOP - McGuireWoods healthcare reform guide: installment No. 53
  • McGuireWoods LLP
  • USA
  • August 20 2015

This is the 53rd in a series of WorkCite articles concerning the Patient Protection and Affordable Care Act and its companion statute, the Health


The “Cadillac tax”: a tankful of issues
  • McGuireWoods LLP
  • USA
  • August 7 2015

This is the 52nd in a series of WorkCite articles concerning the Patient Protection and Affordable Care Act and its companion statute, the Health


Lab company helping physicians establish laboratories may violate anti-kickback statute
  • McGuireWoods LLP
  • USA
  • July 3 2013

Even though federal healthcare program beneficiaries were excluded, a recent Advisory Opinion by the Office of the Inspector General (OIG) of the


AbbVie requests biosimilar labeling modification
  • McGuireWoods LLP
  • USA
  • August 12 2015

On August 10, AbbVie, Inc. filed a supplement to its earlier filed Citizen Petition, levying another challenge to FDA's implementation of the


CMS announces a proposed significant payment reduction for ESRD services
  • McGuireWoods LLP
  • USA
  • July 3 2013

On July 1, 2013, the Centers for Medicare and Medicaid Services (CMS) issued a proposed rule (Proposed Rule) regarding the End-Stage Renal Disease


Investing in dental practice management: key issues and notable transactions
  • McGuireWoods LLP
  • USA
  • October 23 2012

The dental practice management model has become an increasingly popular investment vehicle with management companies and private equity firms


Congress expands Medicare coverage for acute dialysis services
  • McGuireWoods LLP
  • USA
  • July 10 2015

On June 29, 2015, President Obama signed into law the Trade Preferences Extension Act of 2015, which provides for Medicare reimbursement for renal